Is there a role for immunoblots in the diagnosis of latex allergy? Intermethod comparison of in vitro and in vivo IgE assays in spina bifida patients

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 55, Issue 5, 2000, Pages 476-483

  Grüber, Christoph ^a,b   Buck, D ^a   Wahn, U ^a   Niggemann, B ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Diagnosis; Glove provocation; Immunoassay; Immunoblotting; Latex allergy; Skin prick test; Specific IgE; Spina bifida

Indexed keywords

IMMUNOGLOBULIN E; LATEX;

ADOLESCENT; ADULT; ALLERGY; ARTICLE; CHILD; DIAGNOSTIC VALUE; FEMALE; GLOVE; HIGH RISK PATIENT; HUMAN; IMMUNOASSAY; IMMUNOBLOTTING; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRICK TEST; PRIORITY JOURNAL; PROVOCATION TEST; QUESTIONNAIRE; SPINA BIFIDA;

EID: 0034058936     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2000.00364.x     Document Type: Article

References (38)

1. 1. SLATER JE, MOSTELLO LA, SHAER C. Rubber-specific IgE in children with spina bifida. J Urol 1991;146:578-579.
2. 2. BEAUDOUIN E, PRESTAT F, SCHMITT M, KANNY G, LAXENAIRE MC, MONERET-VAUTRIN DA. High risk of sensitization to latex in children with spina bifida. Eur J Pediatr Surg 1994;4:90-93.
3. 3. KELLY KJ, KURUP V, ZACHARISEN M, RESNICK A, FINK JN. Skin and serologic testing in the diagnosis of latex allergy. J Allergy Clin Immunol 1993;91:1140-1145.
4. 4. MICHAEL T, NIGGEMANN B, MOERS A, SEIDEL U, SCHEFFNER D, WAHN U. Risk factors for latex allergy in patients with spina bifida. Clin Exp Allergy 1996;26:934-939.
5. 5. TOSI LL, SLATER JE, SHAER C, MOSTELLO LA. Latex allergy in spina bifida patients: prevalence and surgical implications. J Pediatr Orthop 1993;13:709-712.
6. 6. YASSIN MS, SANYURAH S, LIERL MB, et al. Evaluation of latex allergy in patients with myelomeningocele. Ann Allergy 1992;69:207-211.
7. 7. NIGGEMANN B, BUCK D, MICHAEL T, WAHN U. Latex provocation tests in patients with spina bifida: who is at risk of becoming symptomatic? J Allergy Clin Immunol 1998;102:665-670.
8. 8. LIEBKE C, NIGGEMANN B, WAHN U. Sensitivity and allergy to latex in utopic and non-atopic children. Pediatr Allergy Immunol 1996;7:103-107.
9. 9. SPANER D, DOLOVICH J, TARIO S. Hypersensitivity to natural latex. J Allergy Clin Immunol 1989;83:1135-1137.
10. 10. NIGGEMANN B, MICHAEL T, VON MOERS A, et al. Comparison of three immunoassays for diagnosing sensitization to latex in children with spina bifida. Pediatr Allergy Immunol 1996;7:164-166.
11. 11. KLEINE-TEBBE J, EICKHOLE M, GÄTJEN M, BRUNNÉ T, O'CONNOR A, KUNKEL G. Comparison between Magic Lite-and CAP-system: two automated specific IgE antibody assays. Clin Exp Allergy 1992;22:475-484.
12. 12. WILLIAMS PB, DOLEN WK, KOFPKE JW, SELNER JC. Comparison of skin testing and three in vitro assays for specific IgE in the clinical evaluation of immediate hypersensitivity. Ann Allergy 1992;68:35-45.
13. 13. OWNBY DR, OWNBY HE, MCCULLOUGH J, SHAFER AW. The prevalence of antilatex IgE antibodies in 1000 volunteer blood donors. J Allergy Clin Immunol 1996;97:1188-1192.
14. 14. ERIKSSON NE. Allergy screening with Phadiatop® and CAP Phadiatop® in combination with a questionnaire in adults with asthma and rhinitis. Allergy 1990;45:285-292.
15. 15. BAUR X, CHEN Z, RAULF-HEIMSOTH M, DEGENS P. Protein and allergen content of various natural latex articles. Allergy 1997;52:661-664.
16. 16. CHAMBEYRON C, DRY J, LEYNADIER F, PECQUET C, TRAN XUAN THAO. Study of the allergenic fractions of latex. Allergy 1992;47:92-97.
17. 17. BREITENFDER H, SCHEINER O. Molecular and immunological characteristics of latex allergens. Int Arch Allergy Immunol 1998;116:83-92.
18. 18. KURUP VP, ALENIUS H, KELLY KJ, CASTILLO L, FINK JN. A two-dimensional electrophoretic analysis of latex peptides reacting with IgE and IgG antibodies from patients with latex allergy. Int Arch Allergy Immunol 1996;109:58-67.
19. 19. CHARDIN H, MAYER C, DESVAUX FX, SÉNÉCHAL H, PELTRE G. Latex allergy: characterization of major allergens and isotypic expression. Allergy 1999;55:872-877.
20. 20. DE SWERT LF, VAN LAER KM, VERPOORTEN CM, VAN HOEYVELD EM, CADOT P, STEVENS EA. Determination of independent risk factors and comparative analysis of diagnostic methods for immediate type latex allergy in spina bifida patients. Clin Exp Allergy 1997;27:1067-1076.
21. 21. BLANCO C, CARRILLO T, ORTEGA N, ALVAREZ M, DOMINGUEZ C, CASTILLO R. Comparison of skin-prick test and specific serum IgE determination for the diagnosis of latex allergy. Clin Exp Allergy 1998;28:971-976.
22. 22. EBO DG, STEVENS WJ, BRIDTS CH, DE CLERCK LS. Latex-specific IgE, skin testing, and lymphocyte transformation to latex in latex allergy. J Allergy Clin Immunol 1997;100:618-623.
23. 23. KIM KT, SAFADI GS. Relation of latex-specific IgE titer and symptoms in patients allergic to latex. J Allergy Clin Immunol 1999;103:671-677.
24. 24. KIM KT, SAFADI GS, SHEIKH KM. Diagnostic evaluation of type I latex allergy. Ann Allergy Asthma Immunol 1998;80:66-70.
25. 25. LEBENBORN-MANSOUR MH, OESTERLE JR, OWNBY DR, JENNET MK, POST SK. ZAGLANICZY K. The incidence of latex sensitivity in ambulatory surgical patients: a correlation of historical factors with positive serum immunoglobulin E levels. Anesth Analg 1997;85:44-49.
26. 26. MAZON A, NIETO A, ESTORNELL F, NIETO A, REIG C, GARCIA-IBARRA F. Factors that influence the presence of symptoms caused by latex allergy in children with spina bifida. J Allergy Clin Immunol 1997;99:600-604.
27. 27. BROWN RH, SCHAUBLE JF, HAMILTON RG. Prevalence of latex allergy among anesthesiologists. Identification of sensitized but asymptomatic individuals. Anesthesiology 1998;89:292-299.
28. 28. HAMILTON RG, BIAGINI RE, KRIEG EF, and the Multi-Center Latex Skin Testing Study Task Force. Diagnostic performance of Food and Drug Administration-cleared serologic assays for natural rubber latex-specific IgE antibody. J Allergy Clin Immunol 1999;103:925-930.
29. 29. ALENIUS H, PALOSUO T, KELLY K, et al. IgE reactivity to 14 kD and 27 kD natural rubber proteins in latex-allergic children with spina bifida and other congenital anomalies. Int Arch Allergy Immunol 1993;102:61-66.
30. 30. LU LJ, KURUP VP, HOFFMAN DR, KELLY KJ, MURALI PS, FINK JN. Characterization of a major latex allergen associated with hypersensitivity in spina bifida patients. J Immunol 1995;155:2721-2728.
31. 31. YEANG HY, CHEONG KF, SUNDERASAN E, et al. The 14.6 kd rubber elongation factor (Hev b 1) and 24 kd (Hev b 3) rubber particle proteins are recognized by IgE from patients with spina bifida and latex allergy. J Allergy Clin Immunol 1996;98:628-639.
32. 32. ALENIUS H, KALKKINEN N, YIP E, et al. Significance of rubber elongation factor as a latex allergen. Int Arch Allergy Immunol 1996;109:362-368.
33. 33. CHEN Z, CREMER R, POSCH A, RAULF-HEIMSOTH M, RIHS HP, BAUR X. On the allergenicity of Hev b 1 among health care workers and patients with spina bifida allergic to natural rubber latex. J Allergy Clin Immunol 1997;100:684-693.
34. 34. YLITALO L, ALENIUS H, TURJANMAA K, PALOSUO T, REUNALA T. IgE antibodies to prohevein, hevein, and rubber elongation factor in children with latex allergy. J Allergy Clin Immunol 1998;102:659-664.
35. 35. MARAIS GI, FLETCHER JM, POTTER PC. In vivo and in vitro diagnosis of latex allergy at Groote Schuur Hospital. S Afr Med J 1997;87:1004-1008.
36. 36. BERNARDINI R, NOVEMBRE E, LOMBARDI E, et al. Risk factors for latex allergy in patients with spina bifida and latex sensitization. Clin Exp Allergy 1999;29:681-686.
37. 37. DIEZ-GOMEZ ML, QUIRCE S, CUEVAS M, et al. Fruit-pollen-latex cross-reactivity: implication of profilin. Allergy 1999;55:951-961.
38. 38. BLANCO C, DIAZ-PERALES A, COLLADA C, et al. Class I chitinases as potential panallergens involved in the latex-fruit syndrome. J Allergy Clin Immunol 1999;103:507-513.